Page 2 - Thomasf Gajewski News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomasf gajewski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomasf Gajewski Today - Breaking & Trending Today

Jounce Therapeutics (NASDAQ:JNCE) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a report issued on Monday morning. The brokerage issued a hold rating on the stock. A number of other research analysts have also recently commented on JNCE. Piper Sandler cut shares of Jounce Therapeutics from an overweight rating to a neutral rating […] ....

United Kingdom , Thomasf Gajewski , Kevinc Tang , Robert Schreiber , Raymond James , Piper Sandler , Louism Weiner , Jamesp Allison , Padmanee Sharma , Sumitomo Mitsui Financial Group , Panagora Asset Management Inc , Dimensional Fund Advisors , Charles Schwab Investment Management Inc , Securities Exchange Commission , Prudential Financial Inc , Jounce Therapeutics Inc , Vanguard Group Inc , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Therapeutics Trading Down , Director Richard , Exchange Commission , Asset Management , Fund Advisors , Charles Schwab Investment Management ,

Jounce Therapeutics (NASDAQ:JNCE) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research report released on Monday morning. The brokerage issued a hold rating on the stock. Several other research firms have also issued reports on JNCE. Sumitomo Mitsui Financial Group reissued a neutral rating on shares of Jounce Therapeutics in a report […] ....

United Kingdom , Piper Sandler , Padmanee Sharma , Jamesp Allison , Thomasf Gajewski , Louism Weiner , Raymond James , Robert Schreiber , Kevinc Tang , Susquehanna International Group , Balyasny Asset Management , Jounce Therapeutics Inc , Investment Advisers , Securities Exchange Commission , Connor Clark Lunn Investment Management Ltd , Jounce Therapeutics Company Profile , Sumitomo Mitsui Financial Group , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Director Richard , Exchange Commission , Asset Management , Lunn Investment Management , International Group , Jounce Therapeutics Daily ,

Jounce Therapeutics (NASDAQ:JNCE) Now Covered by Analysts at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the stock. JNCE has been the subject of several other reports. Piper Sandler cut Jounce Therapeutics from an “overweight” rating to a […] ....

United States , United Kingdom , Raymond James , Thomasf Gajewski , Kevinc Tang , Robert Schreiber , Jamesp Allison , Padmanee Sharma , Piper Sandler , Louism Weiner , Silverarc Capital Management , American International Group Inc , Sumitomo Mitsui Financial Group , Jounce Therapeutics Inc , Cubist Systematic Strategies , Securities Exchange Commission , Principal Financial Group Inc , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Exchange Commission , Director Richard , Capital Management , International Group , Financial Group , Systematic Strategies ,

Short Interest in Jounce Therapeutics, Inc. (NASDAQ:JNCE) Declines By 11.4%

Jounce Therapeutics, Inc. (NASDAQ:JNCE – Get Rating) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 2,020,000 shares, a drop of 11.4% from the March 31st total of 2,280,000 shares. Based on an average trading volume of 2,640,000 shares, the days-to-cover ratio is […] ....

United Kingdom , Louism Weiner , Padmanee Sharma , Piper Sandler , Raymond James , Jamesp Allison , Robert Schreiber , Kevinc Tang , Thomasf Gajewski , Health Sciences , Virtu Financial , Susquehanna International Group , Capital Management , Moloney Securities Asset Management , Jounce Therapeutics Inc , Sumitomo Mitsui Financial Group , Securities Exchange Commission , Jounce Therapeutics , Get Rating , Exchange Commission , Director Richard , International Group , Securities Asset Management , Mitsui Financial Group , Jounce Therapeutics Daily , Nasdaq Jnce ,

Jounce Therapeutics (NASDAQ:JNCE) Now Covered by StockNews.com

StockNews.com started coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the stock. A number of other analysts have also weighed in on the stock. Sumitomo Mitsui Financial Group restated a neutral rating on shares of Jounce […] ....

United Kingdom , Raymond James , Robert Schreiber , Louism Weiner , Jamesp Allison , Kevinc Tang , Padmanee Sharma , Piper Sandler , Thomasf Gajewski , Jounce Therapeutics Company Profile , Investment Advisers , Virtu Financial , Capital Management , Securities Exchange Commission , Squarepoint Ops , Voya Investment Management , Sumitomo Mitsui Financial Group , Jounce Therapeutics Inc , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Exchange Commission , Director Richard , Investment Management , Jounce Therapeutics Daily , Nasdaq Jnce ,